Advances in Biotherapy for Knee Joint Disorders Presented at ESSKA
Recent Advances in Biotherapy for Knee Disorders
In recent developments shared at the esteemed ESSKA (European Society of Sports Traumatology, Knee Surgery and Arthroscopy) conference held in Prague from May 20 to 22, 2026, an innovative study on biotherapy for knee joint disorders was unveiled. Dr. Hiroto Hanai, from the Knee Joint Osteoarthritis Clinic, presented groundbreaking clinical research that has garnered international recognition. Hosted by one of the largest academic bodies in Europe focused on knee surgery and sports orthopedics, the conference featured participation from over 15,000 experts across more than 100 countries.
Significance of the Research
The focus of this research is the development of new biotherapy options like the “PFC-FD™ injection,